Comments
Loading...
Astera Labs Analyst Ratings and Price Targets | NASDAQ:ALAB | Benzinga
Astera Labs Inc has a consensus price target of $105.85 based on the ratings of 13 analysts. The high is $140 issued by Needham on February 11, 2025. The low is $65 issued by Jefferies on August 7, 2024. The 3 most-recent analyst ratings were released by Stifel, Citigroup, and Raymond James on April 17, 2025, April 14, 2025, and March 14, 2025, respectively. With an average price target of $94 between Stifel, Citigroup, and Raymond James, there's an implied 47.80% upside for Astera Labs Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Stifel
Citigroup
Raymond James
Craig-Hallum
Needham
1calculated from analyst ratings
Analyst Ratings for Astera Labs
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/17/2025 | Buy Now | 57.24% | Stifel | Tore Svanberg70% | $150 → $100 | Maintains | Buy | Get Alert |
| 04/14/2025 | Buy Now | 57.24% | Citigroup | Atif Malik77% | $120 → $100 | Maintains | Buy | Get Alert |
| 03/14/2025 | Buy Now | 28.94% | Raymond James | Srini Pajjuri77% | → $82 | Initiates | → Outperform | Get Alert |
| 02/11/2025 | Buy Now | 96.55% | Craig-Hallum | Richard Shannon70% | $105 → $125 | Maintains | Buy | Get Alert |
| 02/11/2025 | Buy Now | 120.13% | Needham | Quinn Bolton76% | $140 → $140 | Reiterates | Buy → Buy | Get Alert |
| 01/28/2025 | Buy Now | 79.25% | Morgan Stanley | Joseph Moore68% | $142 → $114 | Maintains | Equal-Weight | Get Alert |
| 01/28/2025 | Buy Now | 88.69% | Northland Capital Markets | Gus Richard59% | $120 → $120 | Upgrade | Market Perform → Outperform | Get Alert |
| 01/21/2025 | Buy Now | 123.28% | Morgan Stanley | Joseph Moore68% | $142 → $142 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 01/17/2025 | Buy Now | 112.27% | Barclays | Tom O'Malley52% | $87 → $135 | Maintains | Overweight | Get Alert |
| 01/06/2025 | Buy Now | 135.86% | Stifel | Tore Svanberg70% | $100 → $150 | Maintains | Buy | Get Alert |
| 01/02/2025 | Buy Now | 88.69% | Northland Capital Markets | Gus Richard59% | $100 → $120 | Downgrade | Outperform → Market Perform | Get Alert |
| 12/20/2024 | Buy Now | 123.28% | Morgan Stanley | Joseph Moore68% | $94 → $142 | Maintains | Overweight | Get Alert |
| 11/18/2024 | Buy Now | 88.69% | Citigroup | Atif Malik77% | → $120 | Initiates | → Buy | Get Alert |
| 11/05/2024 | Buy Now | 65.1% | Roth MKM | Suji Desilva70% | $80 → $105 | Maintains | Buy | Get Alert |
| 11/05/2024 | Buy Now | 47.8% | Morgan Stanley | Joseph Moore68% | $74 → $94 | Maintains | Overweight | Get Alert |
| 11/05/2024 | Buy Now | 57.24% | Stifel | Tore Svanberg70% | $80 → $100 | Maintains | Buy | Get Alert |
| 11/05/2024 | Buy Now | 72.96% | JP Morgan | Harlan Sur75% | $70 → $110 | Maintains | Overweight | Get Alert |
| 11/05/2024 | Buy Now | 57.24% | Deutsche Bank | Ross Seymore81% | $60 → $100 | Maintains | Buy | Get Alert |
| 11/05/2024 | Buy Now | 65.1% | Craig-Hallum | Richard Shannon70% | $75 → $105 | Maintains | Buy | Get Alert |
| 11/05/2024 | Buy Now | 36.8% | Barclays | Tom O'Malley52% | $70 → $87 | Maintains | Overweight | Get Alert |
| 10/09/2024 | Buy Now | 16.36% | Morgan Stanley | Joseph Moore68% | $55 → $74 | Maintains | Overweight | Get Alert |
| 10/09/2024 | Buy Now | 2.21% | Needham | Quinn Bolton76% | $65 → $65 | Reiterates | Buy → Buy | Get Alert |
| 09/04/2024 | Buy Now | -13.52% | Morgan Stanley | Joseph Moore68% | $55 → $55 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 08/07/2024 | Buy Now | 2.21% | Jefferies | Blayne Curtis67% | $85 → $65 | Maintains | Buy | Get Alert |
| 08/07/2024 | Buy Now | 10.07% | JP Morgan | Harlan Sur75% | $95 → $70 | Maintains | Overweight | Get Alert |
| 08/07/2024 | Buy Now | -5.66% | Deutsche Bank | Ross Seymore81% | $85 → $60 | Maintains | Buy | Get Alert |
| 08/07/2024 | Buy Now | -5.66% | Roth MKM | Suji Desilva70% | $85 → $60 | Maintains | Buy | Get Alert |
| 08/07/2024 | Buy Now | 10.07% | Barclays | Tom O'Malley52% | $85 → $70 | Maintains | Overweight | Get Alert |
| 08/07/2024 | Buy Now | -13.52% | Morgan Stanley | Joseph Moore68% | $85 → $55 | Maintains | Equal-Weight | Get Alert |
| 08/07/2024 | Buy Now | 17.93% | Craig-Hallum | Richard Shannon70% | $90 → $75 | Maintains | Buy | Get Alert |
| 08/07/2024 | Buy Now | 25.79% | Evercore ISI Group | Mark Lipacis70% | $98 → $80 | Maintains | Outperform | Get Alert |
| 08/07/2024 | Buy Now | 2.21% | Needham | Quinn Bolton76% | $85 → $65 | Maintains | Buy | Get Alert |
| 08/05/2024 | Buy Now | 25.79% | Stifel | Tore Svanberg70% | $87 → $80 | Maintains | Buy | Get Alert |
| 05/08/2024 | Buy Now | 33.65% | Needham | Quinn Bolton76% | $85 → $85 | Reiterates | Buy → Buy | Get Alert |
| 04/16/2024 | Buy Now | 57.24% | Evercore ISI Group | Mark Lipacis70% | → $100 | Initiates | → Outperform | Get Alert |
| 04/15/2024 | Buy Now | 33.65% | Roth MKM | Suji Desilva70% | → $85 | Initiates | → Buy | Get Alert |
| 04/15/2024 | Buy Now | 33.65% | Jefferies | Blayne Curtis67% | → $85 | Initiates | → Buy | Get Alert |
| 04/15/2024 | Buy Now | 41.51% | Craig-Hallum | Richard Shannon70% | → $90 | Initiates | → Buy | Get Alert |
| 04/15/2024 | Buy Now | 33.65% | Barclays | Tom O'Malley52% | → $85 | Initiates | → Overweight | Get Alert |
| 04/15/2024 | Buy Now | 33.65% | JP Morgan | Harlan Sur75% | → $85 | Initiates | → Overweight | Get Alert |
| 04/15/2024 | Buy Now | 27.36% | Stifel | Tore Svanberg70% | → $81 | Initiates | → Buy | Get Alert |
| 04/15/2024 | Buy Now | 33.65% | Needham | Quinn Bolton76% | → $85 | Initiates | → Buy | Get Alert |
| 04/15/2024 | Buy Now | 27.36% | Morgan Stanley | Joseph Moore68% | → $81 | Initiates | → Equal-Weight | Get Alert |
| 04/15/2024 | Buy Now | 33.65% | Deutsche Bank | Ross Seymore81% | → $85 | Initiates | → Buy | Get Alert |
| 03/25/2024 | Buy Now | 33.65% | Northland Capital Markets | Gus Richard59% | → $85 | Initiates | → Outperform | Get Alert |
FAQ
What is the target price for Astera Labs (ALAB) stock?
The latest price target for Astera Labs (NASDAQ:ALAB) was reported by Stifel on April 17, 2025. The analyst firm set a price target for $100.00 expecting ALAB to rise to within 12 months (a possible 57.24% upside). 34 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Astera Labs (ALAB)?
The latest analyst rating for Astera Labs (NASDAQ:ALAB) was provided by Stifel, and Astera Labs maintained their buy rating.
When was the last upgrade for Astera Labs (ALAB)?
The last upgrade for Astera Labs Inc happened on January 28, 2025 when Northland Capital Markets raised their price target to $120. Northland Capital Markets previously had a market perform for Astera Labs Inc.
When was the last downgrade for Astera Labs (ALAB)?
The last downgrade for Astera Labs Inc happened on January 21, 2025 when Morgan Stanley changed their price target from $142 to $142 for Astera Labs Inc.
When is the next analyst rating going to be posted or updated for Astera Labs (ALAB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Astera Labs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Astera Labs was filed on April 17, 2025 so you should expect the next rating to be made available sometime around April 17, 2026.
Is the Analyst Rating Astera Labs (ALAB) correct?
While ratings are subjective and will change, the latest Astera Labs (ALAB) rating was a maintained with a price target of $150.00 to $100.00. The current price Astera Labs (ALAB) is trading at is $63.60, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
